Dr Reddy's Laboratories Launches Generic Sugammadex Injection in US Market
Dr Reddy's Laboratories has launched a generic version of Sugammadex injection in the United States, used to reverse muscle relaxants during surgery. Available in 200 mg and 500 mg single-dose vials, this product is a generic equivalent of Bridion, which had US sales of about USD 1.6 billion in the past year. Manufactured through Dr Reddy's global supply network, the launch expands the company's hospital portfolio and aims to improve patient access to affordable medicines.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (55/100). Lens Score 36/100.
Outlets measured: economictimes, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 4 Aug, 08:15 am. Other outlets followed.
- 1